These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36354102)

  • 1. Mesorectal excision with or without lateral lymph node dissection for elderly patients with mid-low rectal cancer: safety and feasibility analysis.
    Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q;
    Jpn J Clin Oncol; 2023 Jan; 53(1):26-34. PubMed ID: 36354102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and safety of lateral pelvic lymph node dissection for elderly patients with middle-low rectal cancer: results of a large multicenter lateral node collaborative group study in China.
    Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q
    Tech Coloproctol; 2023 Aug; 27(8):655-664. PubMed ID: 36515808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
    Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
    Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transanal lateral lymph node dissection surgery for 5 cases of mid-low rectal cancer].
    Zeng ZW; Zhang XW; Chen JJ; Huang L; Luo SL; Kang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):781-785. PubMed ID: 31422618
    [No Abstract]   [Full Text] [Related]  

  • 5. [Short-term efficacy of robotic-assisted total mesorectal excision with and without lateral lymph node dissection for mid-low advanced rectal cancer: a propensity score matching analysis].
    Shi FY; Zhang L; Qin Q; Jin X; Hu CH; Yu TY; Ma L; Wang GH; Wu H; Xia P; Sun XJ; She JJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):370-376. PubMed ID: 32306605
    [No Abstract]   [Full Text] [Related]  

  • 6. Lateral lymph node dissection for mid-to-low rectal cancer: is it safe and effective in a practice-based cohort?
    Numata M; Tamagawa H; Kazama K; Kawahara S; Sawazaki S; Aoyama T; Maezawa Y; Kano K; Higuchi A; Godai T; Saigusa Y; Saeki H; Yukawa N; Rino Y
    BMC Surg; 2021 Jan; 21(1):51. PubMed ID: 33478441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic Versus Open Lateral Lymph Node Dissection for Locally Advanced Low Rectal Cancer: A Subgroup Analysis of a Large Multicenter Cohort Study in Japan.
    Yamaguchi T; Konishi T; Kinugasa Y; Yamamoto S; Akiyoshi T; Okamura R; Ito M; Nishimura Y; Shiozawa M; Yamaguchi S; Hida K; Sakai Y; Watanabe M
    Dis Colon Rectum; 2017 Sep; 60(9):954-964. PubMed ID: 28796734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery.
    Hajibandeh S; Hajibandeh S; Matthews J; Palmer L; Maw A
    Surgery; 2020 Sep; 168(3):486-496. PubMed ID: 32620303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
    Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
    World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term outcomes of laparoscopic versus open selective lateral pelvic lymph node dissection for locally advanced middle-low rectal cancer: Results of a multicentre lateral node study in China.
    Tang J; Zhou S; Zhao W; Lou Z; Liang J; Feng B; Yang Y; Wang X; Liu Q;
    Colorectal Dis; 2022 Nov; 24(11):1325-1334. PubMed ID: 35713974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of lateral pelvic lymph node dissection with total mesorectal excision in treatment of rectal cancer: A systematic review and meta-analysis.
    Emile SH; Elfeki H; Shalaby M; Sakr A; Kim NK
    Surgery; 2021 May; 169(5):1005-1015. PubMed ID: 33317903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212).
    Ito M; Kobayashi A; Fujita S; Mizusawa J; Kanemitsu Y; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y;
    Eur J Surg Oncol; 2018 Apr; 44(4):463-468. PubMed ID: 29428473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the short-term surgical outcomes of lateral lymph node dissection for low rectal cancer using a robotic-assisted transabdominal approach alone or supported by a transanal approach.
    Tokunaga T; Kashihara H; Yoshikawa K; Nakao T; Nishi M; Takasu C; Wada Y; Yoshimoto T; Shimada M
    Surg Endosc; 2024 Apr; 38(4):2070-2077. PubMed ID: 38438675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Feasibility of a three-sided encapsulation procedure based on fascia anatomy in laparoscopic lateral lymph node dissection for middle and low rectal cancer].
    Li WJ; Diao DC; Lin JX; Wang JH; Liao WL; Tang X; Xie JX; Ao L; Zhang XY; Yi XJ; Feng XC; Li HM; Lu XQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Oct; 26(10):968-976. PubMed ID: 37849268
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison on efficacy between fascia-oriented versus vascular-oriented lateral lymph node dissection in patients with rectal cancer].
    Wang ZJ; Liu Z; Liang JW; Zhang MG; Mei SW; Shen HY; Chen JN; Li J; Zhao FQ; Wei FZ; Xiao TX; Liu Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jul; 24(7):611-618. PubMed ID: 34289546
    [No Abstract]   [Full Text] [Related]  

  • 16. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
    Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
    Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
    Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
    [No Abstract]   [Full Text] [Related]  

  • 18. Short- and long-term outcomes of laparoscopic versus open lateral lymph node dissection for locally advanced middle/lower rectal cancer using a propensity score-matched analysis.
    Watanabe J; Ishibe A; Suwa Y; Ozawa M; Nakagawa K; Suwa H; Ota M; Kunisaki C; Endo I
    Surg Endosc; 2021 Aug; 35(8):4427-4435. PubMed ID: 32875413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological outcomes of robotic-assisted laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer.
    Yamaguchi T; Kinugasa Y; Shiomi A; Kagawa H; Yamakawa Y; Furutani A; Manabe S; Yamaoka Y; Hino H
    Surg Endosc; 2018 Nov; 32(11):4498-4505. PubMed ID: 29721748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.